MiR-373-3p by targeting CCND2 could inhibit cell propagation, migration, and invasion, and boost apoptosis, chemosensitivity, and G0/G1 arrest in gemcitabine resistance pancreatic carcinoma cells. Here, CCND2 is linked to exocrine pancreatic carcinoma.